Rabies clinical trials
The registry lists 119 studies for Rabies across more than 10 countries. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-07-17.
Status
- Completed
- 83
- Status unknown
- 12
- Not yet recruiting
- 11
- Active, not recruiting
- 5
- Terminated
- 3
- Recruiting
- 2
Phase
- Phase 3
- 38
- Phase 2
- 22
- Phase 4
- 18
- Phase 1
- 18
- Early Phase 1
- 2
Where
- China
- 36
- United States
- 19
- Thailand
- 16
- Philippines
- 7
- Germany
- 6
- Pakistan
- 5
Who runs them
Sanofi Pasteur, a Sanofi Company (13) · Queen Saovabha Memorial Institute (9) · Novartis Vaccines (6) · Synermore Biologics (Suzhou) Co., Ltd. (6) · Sinovac Biotech Co., Ltd (5) · GlaxoSmithKline (4) · Beijing Center for Disease Control and Prevention (4) · Jiangsu Province Centers for Disease Control and Prevention (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 119 — search for more.
- An Expanded Access Program for SYN023 in Rabies TreatmentAvailableNCT07706907
- Real World Evidence Study of SYN023 in Children Exposed to RabiesRecruitingNCT073273071 country
- Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.Not yet recruitingNCT07455318Phase 31 country
- A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal AntibodyNot yet recruitingNCT07445815Phase 21 country
- Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies VaccineNot yet recruitingNCT07416110Phase 31 country
- Safety and Immunogenicity of ID vs IM Rabies VaccineNot yet recruitingNCT07345208Phase 2/31 country
- Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed VaccineNot yet recruitingNCT07168018Phase 21 country
- Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis RegimenNot yet recruitingNCT07055893Phase 31 country
- Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)Not yet recruitingNCT07055880Phase 21 country
- Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis RegimenNot yet recruitingNCT07055295Phase 31 country
- Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)Not yet recruitingNCT07028801Phase 31 country
- A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-driedRecruitingNCT07021703Phase 11 country
- Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical TrialsNot yet recruitingNCT06548139Phase 21 country
- Prevention of Rabies With Four Doses of Rabies VaccineEnrolling by invitationNCT05545371Phase 31 country
- Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)Not yet recruitingNCT05969626Phase 31 country
- Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of RabiesCompletedNCT03961555Phase 22 countries
- Study of Intradermal Administration of PCEC Rabies VaccineCompletedNCT01044199Not applicable1 country
- Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in NanyangActive, not recruitingNCT076244611 country
- A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy AdultsCompletedNCT06998004Phase 11 country
- A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 YearsActive, not recruitingNCT07275645Phase 31 country
- Adherence to Anti-rabies Post-exposure Prophylactic ProtocolsCompletedNCT070120831 country
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of AdultsCompletedNCT04127786Phase 31 country
- Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-driedCompletedNCT07357545Phase 31 country
- SYN023 With Rabies Vaccine in Healthy Pediatric SubjectsCompletedNCT07342257Phase 11 country
- A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 YearsCompletedNCT06132789Phase 11 country
- A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabGActive, not recruitingNCT04270838Phase 1/21 country
- Survey of Human Rabies Immune Globulin Safety in ChildrenTerminatedNCT053826501 country
- Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in ThaïlandCompletedNCT04594551Phase 31 country
- Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in ThaïlandCompletedNCT04478084Phase 31 country
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in AdultsCompletedNCT03965962Phase 31 country
- A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy AdultsCompletedNCT03713086Phase 12 countries
- Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabGTerminatedNCT04162600Phase 11 country
- Study to Evaluate GR1801's Efficacy and SafetyCompletedNCT05846568Phase 31 country
- A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-driedActive, not recruitingNCT05667974Phase 32 countries
- A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.CompletedNCT02545517Phase 33 countries
- Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult SubjectsCompletedNCT04019444Phase 11 country
- Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and IntradermallyCompletedNCT06433440Phase 41 country
- Vaccine Prevention of Rabies Adopts 4-shot Immunization MethodCompletedNCT05549908Phase 31 country
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy AdultsCompletedNCT04062669Phase 11 country
- To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)CompletedNCT06177249Phase 31 country
- A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)Active, not recruitingNCT04852068Phase 31 country
- A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)CompletedNCT06078423Phase 31 country
- The Role of Fatty Acids in Vaccine EfficacyCompletedNCT05987384Not applicable1 country
- Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and IntradermallyCompletedNCT05937113Phase 41 country
- Responses to Rabies Vaccine in Adults With or Without AntibioticsCompletedNCT03557008Phase 41 country
- Integrating Community Interventions to Eliminate Neglected Tropical DiseasesCompletedNCT03667079Not applicable1 country
- Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1Status unknownNCT05832073Early Phase 11 country
- A Phase III Clinical Study to Evaluate SYN023's Efficacy and SafetyCompletedNCT04644484Phase 31 country
- Immunity Persistence After Abridged Intradermal Rabies PEPCompletedNCT04829630Not applicable2 countries
- Social Media as an Information, Education and Communication Tool for Rabies Prevention: An Interventional StudyCompletedNCT05702008Not applicable1 country